Artivila Biopharma
PrivateLast Round
Series A
Jun 25, 2026
Total Funding Raised
$35.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Artivila Biopharma is a biotechnology company that develops innovative drugs for autoimmune diseases, neurodegenerative diseases, and oncology using an AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artivila Biopharma Comparables
Compare Artivila Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 83% | |
| Terray Therapeutics | 79% | |
| Genesis Molecular AI | 79% | |
Artivila Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2026 | ||||
| VC Round | Mar 31, 2022 | ||||
| Seed | Mar 30, 2021 | ||||
| Angel | Nov 1, 2019 |
Artivila Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Seed |
| Hike Capital | VC Round |
| Jiangsu Honghui Equity Investment Management | Seed |
| 幂方资本 | Seed |
| Bopu Asset Management | Angel |
| Anlong Fund | Angel |
| Yijing Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
$13M round led by Green Pine Capital Partners
- Sep 22, 2025
Successful completion of Phase I study for ARD-885, a novel small molecule drug.
Artivila Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artivila Biopharma's valuation, stock price, and market status.